The Arora Report

Rss Facebook Twitter Linkedin

April 5, 2011

CUBIST PHARMACEUTICALS (CBST) ACQUISITION TARGET

Yesterday Cubist (CBST) settled its long running dispute with Teva Pharmaceuticals (TEVA). It appears that this development sets Cubist up to be acquired by a larger player. 

Cubist has received upgrades from several brokers.  At present, cubist satisfies only three screens of  the ZYX Change Method.  We will issue an actionable signal in ZYX BUY CHANGE ALERTS when all six screens are meet.

www.thearorareport.com
THE ARORA REPORT, Ltd.
HOME OF THE UNIQUE ZYX CHANGE METHOD
DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING
VERIFIABLE PERFORMANCE RECORD
Every closed trade since 2007, without exception, is included in the performance results.
… Please click here or the title below to read more.
Read More
April 5, 2011

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy